Medicinal plants are the most important source of life saving drugs for the majority of the world's population. The biotechnological tools are important to select, multiply and conserve the critical genotypes of medicinal plants. Plant tissue culture techniques offer an integrated approach for the production of standardized quality phytopharmaceutical through mass-production of consistent plant material for physiological characterization and analysis of active ingredients. Micropropagation protocols for cloning of some medicinal plants such as Catharanthus roseus (Apocynaceae), Chlorophytum borivilianum (Liliaceae), Datura metel (Solanaceae), and Bacopa monnieri (Scrophulariaceae) have been developed. Regeneration occurred via organogenesis and embryogenesis in response to auxins and cytokinins. The integrated approaches of our culture systems will provide the basis for the future development of novel, safe, effective, and highquality products for consumers.
INTRODUCTION
Recent and renewed interest in medicinal plants coupled to developments in information technology has fuelled an explosion in the range and content of electronic information concerning medicinal plants as a re-emergent health aid. Medicinal plants, since times immemorial, have been used in virtually all cultures as a source of medicine. The widespread use of herbal remedies and healthcare preparations, as those described in ancient texts such as the Vedas and the Bible, and obtained from commonly used traditional herbs and medicinal plants, has been traced to the occurrence of natural products with medicinal properties. Medicinal plants play a key role in world heath care systems [13] . Herbal medicine is one of the most remarkable uses of plant based biodiversity. As many as 75 to 90% of the worlds' rural people rely on herbal medicine for their primary health care. The success of any health care system depends on the availability of suitable drugs on a sustainable basis. Reserves of herbs and stocks of medicinal plants in developing countries are diminishing and in danger of extinction as a result of growing trade demands for cheaper healthcare products and new plant-based therapeutic markets in preference to more expensive target-specific drugs and biopharmaceuticals. Such concerns have stimulated positive legal and economic interest.
In several industrialized societies, plant-derived prescription drugs constitute an element in the maintenance of health. Medicinal plants are an integral component of research developments in the pharmaceutical industry. Such research focuses on the isolation and direct use of active *Address correspondence to this author at the Tissue Culture Laboratory, Institute of Biotechnology and Allied Sciences, Seedling Academy of Design, Technology and Management, Jaipur-302025, India; E-mail: psbisen@gmail.com medicinal constituents, or on the development of semisynthetic drugs, or still again on the active screening of natural products to yield synthetic pharmacologically-active compounds. In Germany, for example, over 1500 plant species encountered in some 200 families and 800 genera have been processed into medicinal products. In South Africa, likewise, some 500 species are commercialized trade products. Today, Bulgaria, Germany and Poland are recognized as major exporters of plant-based medicinal products. India has about 45,000 plant species; medicinal properties have been assigned to several thousand. The world market for herbal derivatives /products is in the increase order of magnitude. In the U.S. and Europe the ecological movement has brought about a renewed interest in traditional medicines. High inflation rates in the third world have caused some citizens to return to or begin using herbal remedies, The prescription drug market is around $40 billion today, suggesting a value of about $10 billion for those drugs containing at least one compound derived from higher plants. Even today, the World Health Organization estimates that up to 80 per cent of people still rely mainly on traditional remedies such as herbs for their medicines.
Medicine, in several developing countries, using local traditions and beliefs, is still the mainstay of health care. As defined by WHO, health is a state of complete physical, mental, and social well being and not merely the absence of disease or infirmity. In Europe, some 1500 species of medicinal and aromatic plants are widely used in Albania, Bulgaria, Croatia, France, Germany, Hungary, Poland, Spain, Turkey, and the United Kingdom ( Table 1) The practice of traditional medicine is widespread in China, India, Japan, Pakistan, Sri Lanka and Thailand. In China about 40% of the total medicinal consumption is attributed to traditional tribal medicines. In Thailand, herbal medicines make use of legumes encountered in the Caesalpiniaceae, the Fabaceae, and the Mimosaceae. In the mid-90s, it is estimated that receipts of more than US$2.5 billion have resulted from the sales of herbal medicines. And, in Japan, herbal medicinal preparations are more in demand than mainstream pharmaceutical products. In total, 75 species belonging to 42 families have been investigated and new ethnomedical information has been obtained for 41 species [67] . Despite the increasing use of medicinal plants, their future, seemingly, is being threatened by complacency concerning their conservation. Globally, the early part of the 20th century brought an evolution of the pharmaceutical industry. With the progress in chemical techniques, crude drugs came to be replaced by pure chemical drugs and the developed countries witnessed a decline in popularity of medicinal plant therapy. However, during the recent past, the pendulum has swung again and there is a resurgence of interest in study and use of medicinal plants. Many traditional plant based remedies are back in use and find increasing applications as:
source of direct therapeutic agents,
(ii) as a raw material base for the elaboration of more complex semi-synthetic chemical compounds,
(iii) as models for new synthetic compounds, and (iv) as taxonomic markers for the discovery of new compounds.
Thus, plants are a tremendous source for the discovery of new products of medicinal value for drug development. Today several distinct chemicals derived from plants are important drugs currently used in one or more countries in the world. A drug "Memory Plus" has recently been developed using Brahmi (Bacopa monniera L.) by the scientists of the Central Drug Research Institute, Lucknow, India. Similar Ayurvedic pills, for rejuvenating humans has come up in the name of "Thirty Plus", which use Ashwagandha (Withania somnifera L.) and Ginseng (Panax aquintifolium) as the ingredients. Pudin Hara, another Ayurvedic drug containing mint ( Mentha arvensis L.), which is used for indigestion, is available across the counter. The production, consumption and international trade in medicinal plants, and phytomedicines, therefore, are growing and expected to grow in future quite significantly. Consumption of herbal medicines is widespread and increasing. Yet harvesting from the wild, the main source of raw material, is causing loss of genetic diversity and habitat destruction.
ECONOMIC BENEFIT
World wide, there has been a renewed interest in natural products. The world market for plant-derived chemicals viz. pharmaceuticals, fragrances, flavors, and color ingredients, alone exceeds several billion dollars per year. Classic examples of phytochemicals in biology and medicine include taxol, vincristine, vinblastine, colchicine ,artemisinin, forkolin, Saponin etc. Trade in medicinal plants is growing in volume and in exports. The $60-billion global herbal market is growing at a rate of 7 percent per annum and is expected to generate $5 trillion by 2050. According to a WHO document, one fourth of the 500 million prescriptions written in the US each year contain a mention of leafy plant extracts. The Indian climate is conductive to herbal cultivation. Developing and emerging countries besides catering to domestic demands have the potential to improve export of plant drugs. For example, China has attained a leader position in the export of crude and Chinese drugs to the world market and it is followed far behind by Singapore and India. The botanical market, inclusive of herbs and medicinal plants, in the USA, is estimated, at retail, at approximately US$1.6 billion p.a. China with exports of over 120,000 tonnes p.a., and India with some 32,000 tonnes p.a. dominate the international markets. It is estimated that Europe, annually, imports about 400,000 tonnes of medicinal plants with an average market value of US$ 1 billion from Africa and Asia. The industry anticipates growth on the order of 15-20% into the new millennium. A growing awareness of this new contributor to the foreign-exchange reserves of several national treasuries is beginning to emerge. To satisfy growing market demands, surveys are being conducted to unearth new plant sources of herbal remedies and medicines at the same time develop new strategies for better yield and quality.
CONVENTIONAL

PLANT-BREEDING AND MICROPROPAGATION
Conventional plant-breeding methods can improve both agronomic and medicinal traits. In vitro propagation or tissue culture of plants holds tremendous potential for the production of high-quality plant-based medicines. This can be achieved through different methods including micropropagation [106] . The evolving commercial importance of secondary metabolites has in recent years resulted in a great interest in secondary metabolism, particularly in the possibility of altering the production of bioactive plant metabolites by means of tissue culture technology. Plant cell culture technologies were introduced at the end of the 1960's as a possible tool for both studying and producing plant secondary metabolites [78] . Different strategies, using an in vitro system, have been extensively studied to improve the production of plant chemicals.
Micropropagation has many advantages over conventional methods of vegetative propagation, which suffer from several limitations. There has been significant progress in the use of tissue culture and genetic transformation to alter pathways for the biosynthesis of target metabolites. Obstacles to bringing medicinal plants into successful commercial cultivation include the difficulty of predicting, which extracts will remain marketable and the likely market preference for what is seen as natural source of extracts.
The most outstanding merits offered by micropropagation, over the conventional methods are:
1. In a relatively short time and space large number of plants can be produced, starting from single explant.
2. Unlike the conventional methods of plant propagation, micropropagation of even temperature species may be carried out throughout the year.
3. Tissue cultured plants are generally free from fungal and bacterial diseases. Virus eradication and maintenance of plants in a virus-free-state are also readily achieved in tissue culture.
4. The multiplication rate is greatly increased.
5. It also permits the production of pathogen-free material. Micropropagation of various plant species, including many medicinal plants, has been reported. Propagation from existing meristems yields plants that are genetically identical with the donor plants. Tissue culture technique has been widely accepted as a tool for biotechnology for vegetative propagation of plants of agricultural, horticultural and forestry importance [14, 20] . Biotechnological tools are important for multiplication and genetic enhancement of the medicinal plants by adopting techniques such as in vitro regeneration and genetic transformations. It can also be harnessed for production of secondary metabolites using plants as bioreactors. The Centre for Science and Technology of the Non-Aligned and other Developing Countries in India organized an international workshop on Tissue Culture of Economic Plants in April, 1994, as a better and quicker means of using modern biotechnological techniques to nurture and conserve medicinal plants.
This paper reviews the achievements and advances in the application of tissue culture for the in vitro regeneration of medicinal plants from various explants and enhanced production of secondary metabolites.
PRODUCTION OF SECONDARY METABOLITES
Pharmaceuticals from Natural Plants Progress in the field of pharmaceuticals have been spectacular. Most valuable phytochemicals are products of plant secondary metabolism.
In the search for alternatives to production of desirable medicinal compounds from plants, biotechnological approaches, specifically, plant tissue cultures, are found to have potential as a supplement to traditional agriculture in the industrial production of bioactive plant metabolites. Secondary metabolites are compounds produced in plants that are not necessary for the plants basic functions although some act as chemical defenses against microbes and animals. Secondary metabolites are used in the pharmaceutical industry as flavorants and dyes, and in perfumery. The development and commercialization of medicinal plant-based bioindustries in the developing countries is dependent upon the availability of facilities and information concerning upstream and downstream bioprocessing, extraction, purification, and marketing of the industrial potential of medicinal plants. As conventional growing of medicinal plants is relatively expensive, production of medicinal and/or other compounds can be elicited in vitro.
The production of secondary metabolite in vitro can be possible through plant cell culture. Successful establishment of cell lines capable of producing high yields of secondary compounds in cell suspension cultures have been reported [107] .
Cell suspension culture systems could be used for large scale culturing of plant cells from which secondary metabolites could be extracted. The advantage of this method is that it can ultimately provide a continuous, reliable source of natural products. Discoveries of cell cultures capable of producing specific medicinal compounds at a rate similar or superior to that of intact plants have accelerated in the last few years. New physiologically active substances of medicinal interest have been found by bioassay. It has been demonstrated that the biosynthetic activity of cultured cells can be enhanced by regulating environmental factors, as well as by artificial selection or the induction of variant clones. Some of the medicinal compounds localized in morphologically specialized tissues or organs of native plants have been produced in culture systems not only by inducing specific organized cultures, but also by undifferentiated cell cultures. The possible use of plant cell cultures for the specific biotransformations of natural compounds has been demonstrated [32, 33] . Due to these advances, research in the area of tissue culture technology for production of plant chemicals has bloomed beyond expectations. The major advantages of a cell culture system over the conventional cultivation of whole plants are:
Useful compounds can be produced under controlled conditions independent of climatic changes or soil conditions;
(2) Cultured cells would be free of microbes and insects; Plant cell culture technologies were introduced at the end of the 1960's as a possible tool for both studying and producing plant secondary metabolites. Different strategies, using an in vitro system, have been extensively studied to improve the production of plant chemicals. In order to obtain high yields suitable for commercial exploitation, efforts have focused on isolating the biosynthetic activities of cultured cells, achieved by optimizing the cultural conditions, selecting high-producing strains, and employing precursor feeding, transformation methods, and immobilization techniques.
Advances in the area of cell cultures for the production of medicinal compounds has made possible the production of a wide variety of pharmaceuticals like alkaloids, terpenoids, steroids, saponins, phenolics, flavanoids, and amino acids. Successful attempts to produce some of these valuable pharmaceuticals in relatively large quantities by cell cultures are discussed below. The accumulation of secondary products in plant cell cultures depends on the composition of the culture medium, and on environmental conditions. Strategies for improving secondary products in suspension cultures, using different media for different species, have been reported [88, 69] . The production of secondary metabolites in plant cell suspension cultures has been reported from various medicinal plants. The production of solasodine from calli of Solanum eleagnifolium, and pyrrolizidine alkaloids from root cultures of Senecio sp. are examples. Cephaelin and emetine were isolated from callus cultures of Cephaelis ipecacuanha. Scragg et al. [88] isolated quinoline alkaloids in significant quantities from globular cell suspension cultures of Cinchona ledgeriana. Enhanced indole alkaloid biosynthesis in the suspension culture of Catharanthus roseus has also been reported [26, 57, 71] . Ravishankar and Grewal [82] reported that the influence of media constituents and nutrient stress influenced the production of diosgenin from callus cultures of Dioscorea deltoidea. Parisi et al. [69] obtained high yields of proteolytic enzymes from the callus tissue culture of garlic (Allium sativum L.) on MS medium supplemented with NAA and BAP. Pradel et al. [73] observed that the biosynthesis of cardenolides was maximal in the hairy root cultures of Digitalis lanata compared to leaf. The production of azadirachtin and nimbin has been shown to be higher in cultured shoots and roots of Azadirachta indica compared to field grown plant. Pande et al. [68] reported that the yield of lepidine from Lepidium sativum Linn. depends upon the source and type of explants.
Research in the area of plant tissue culture technology has resulted in the production of many pharmaceutical substances for new therapeutics. Many of the drugs sold today are simple synthetic modifications or copies of the naturally obtained substances. The evolving commercial importance of secondary metabolites has in recent years resulted in a great interest in secondary metabolism, particularly in the possibility of altering the production of bioactive plant metabolites by means of tissue culture technology. Transgenic hairy root cultures have revolutionized the role of plant tissue culture in secondary metabolite production. They are unique in their genetic and biosynthetic stability, faster in growth, and more easily maintained. Using this methodology a wide range of chemical compounds have been synthesized.
Bioreactors [100] are the key step towards commercial production of secondary metabolites by plant biotechnology. Bioreactors have several advantages for mass cultivation of plant cells:
i. It gives better control for scale up of cell suspension cultures under defined parameters for the production of bioactive compounds;
ii. Constant regulation of conditions at various stages of bioreactor operation is possible;
iii. Handling of culture such as inoculation or harvest is easy and saves time;
iv. Nutrient uptake is enhanced by submerged culture conditions, which stimulate multiplication rate and higher yield of bioactive compounds; and v. Large number of plantlets are easily produced and can be scaled up.
Since the biosynthetic efficiency of populations varies, a high yielding variety should be selected as a starting material. The fundamental requirement in all this is a good yield of the compound, and reduced cost compared to the natural synthesis by the plants.
The bioreactor system has been applied for embryogenic and organogenic cultures of several plant species. Significant amounts of sanguinarine were produced in cell suspension cultures of Papaver somniferum using bioreactors. Ginseng root tissue cultures in a 20 tonne bioreactor produced 500 mg/L/day; of the saponin that is considered as a very good yield. Bioreactors offer optimal conditions for large-scale plant production for commercial manufacture. Much progress has been achieved in the recent past on optimization of these systems for the production and extraction of valuable medicinal plant ingredients such as ginsenosides and shikonin. Roots cultivated in bioreactors have been found to release medicinally active compounds, including the anticancer drug isolated from various Taxus species, into the liquid media of the bioreactor, which may then be continuously extracted for pharmaceutical preparations. Conventional practices require the harvest of the bark of trees, all approximately 100 years old, to obtain 1 kg of the active compound taxol. Research over the last two decades has established efficient protocols for isolated cell cultures and a large-scale bioreactor system. The acceptance of this process for the industrial production of this invaluable compound has recently been established and will significantly impact the production of the tumor-inhibiting pharmaceutical.
MICROPROPAGATION OF SELECTED MEDICINAL PLANTS
Tissue culture is basically defined as in vitro growth of plantlets from any part of the plants in suitable nutritive culture medium. It is also known as 'micropropagation' in scientific technology. Callus-mediated organogenesis and regeneration through somatic embryogenesis are the usual mode of regeneration by tissue culture. The induction of callus growth and subsequent differentiation, organogenesis and somatic embryogenesis are accomplished by the differential application of growth regulators and the control of conditions in the culture medium. With the stimulus of endogenous growth substances or by addition of exogenous growth regulators to the nutrient medium, cell division, and cell growth and tissue differentiation are induced Micropropagation systems have been successfully developed for many medicinal species such as Periwinkle (Catharanthus roseus), Safed Musli (Chlorophytum borivilianum) Brahmi (Bacopa monieri) and Thorn apple (Datura metel).
Periwinkle (Catharanthus roseus)
Catharanthus roseus (Apocynaceae) originated from Madagascar, but has now been spread throughout the tropics and subtropics by human activity.This plant is cultivated as an ornamental plant throughout tropical and subtropical areas and many parts of the world. Catharanthus is a plant belonging to the family, well known for being rich in alkaloids. All parts of plant, especially, the leaves contain antineoplastic bisindole alkaloids, among those are vinblastine and vincristine, which are widely employed as chemotherapeutic agents against cancer. The absolute levels of vinblastine and vincristine are considered far too low to explain the activity of crude extracts of Catharanthus. Various studies show the presence of other antineoplastic alkaloids [72, 86] in the plant. Though its primary traditional use was for people with diabetes, Catharanthus also has anticancer effects. In the intact plant, vindoline is localized in the leaves and catharanthine is found in both the leaves and roots. Ex (Fig. 1) is the first drug of choice in many forms of leukemia and since the 1950s' it has increased the survival rate of childhood leukemias by 80%. Another antileukemic drug, Vincristine (Fig. 1) Plant regeneration from shoot and stem meristems has yielded encouraging results in Catharanthus roseus [60] . Rapid in vitro multiplication of plants from mature nodal explants of Catharanthus roseus have been reported [56] . The effects of auxins, cytokinins, different nutrient media and explant sources on callus induction on shoot multiplication of Catharanthus roseus L.G. Don plant have been studied [3] . In vitro and in vivo cultivation has been a source to study alterations in the growth of a Catharanthus roseus L. callus tissues [106] and cytological investigation [45] have also been studied. In our lab also callus induction ( Fig. 2A) (Fig. 2B ) and shoot elongation (Fig. 2C,D) was observed on MS medium supplemented with NAA (0.5mgl -1 ) and KN(2mgl -1 ). These shoots when transferred to MS medium supplemented with IBA (2mgl -1 ) resulted in rooting. For alkaloid extraction, in vitro plant multiplication is an ideal approach to produce leaf material in large quantity. In vitro heavy metal stress on callus culture [105] and regeneration of pathogen free [40.59] healthy plants through callus culture have been reported.
A number of nutritional factors as well as the growth factors 2,4-D and IAA were studied to determine their influence on growth and alkaloid formation [36, 57, 58, 71, 88] in Catharanthus roseus suspension cultures. Zhao J, et al. [109] studied the effects of stress factors, bioregulators, and synthetic precursors on indole alkaloid production in compact callus clusters cultures of Catharanthus roseus. Large scale fermentation and alkaloid production of cell suspension cul- tures has also been reported [26, 86, 109] . Reports on various factors on the release of secondary metabolites from roots of Datura stramonium, Catharanthus roseus, and Tagetes patula cultured in vitro like effect of the medium pH [85] , sucrose [53] have been reported. Enhanced alkaloid production by transformed root cultures [70] and use of elicitors [26] has also been performed. Quantitative analysis of various alkaloids produced in vitro and in vivo has been extensively done [10, 16, 19, 25] in Catharanthus roseus. Efficient development and germination of somatic embryos are prerequisites for commercial plantlet production. Lowering of growth regulator concentrations in culture media has improved embryo development and germination of many medicinal plants. Germination of the somatic embryos is achievable on MS medium without the growth regulator. High frequency plant regeneration from anther-derived cell suspension cultures via somatic embryogenesis in Catharanthus roseus [41] as well as somatic embryogenesis and indole alkaloid production [72] have been observed in vitro .The suspension culture of Catharanthus roseus from stem and leaf explants on medium containing NAA and kinetin has been established by Zhao et al. [110] . Somatic hybridization and long term stability of electromanipulated protoplasts of Glycine max var. Acme and a Catharanthus roseus mutant [85] has been reported. The effects of various heavy metals cell suspension cultures like cobalt (II) and nickel (II) [111] , aluminum [55, 110] and the regulation of DNA synthesis and cell division by polyamines in Catharanthus roseus suspension cultures [54] has been studied.
Safed musli, Chlorophytum borivilianum
Chlorophytum borivilianum (Liliaceae) commonly known as Safed musli is among the few rare medicinal plants [65] witnessing steadily growing use in pharmaceutical, phyto-pharmaceutical and nutraceutical products. The Medicinal Plants Board has recognized Safed Musli as sixth among the 28 selected priority medicinal plants, important herb to be protected and promoted. The Board encourages mainstream cultivation of Safed Musli by farmers by extending a subsidy of 20% through National Horticultural Board on project cost. The steadily growing demand for Safed Musli has caused its price to soar to Rs.1,500 per Kg in the market [21] , resulting in over exploitation through wild harvesting pushing the plant to the verge of extinction. While the demand for Safed Musli is over 35,000 tons per annum, the supply is only to the tune of 5,000 tons a year.
Chlorophytum borivilianum Santapau & Fernandes is an important herbaceous, medicinal plant found in the forests of Madhya Pradesh and Gujarat states of India. It is a member of the Liliaceae family and perennates by fleshy roots attached to a condensed stem disc, which remains dormant in the soil for about 7 months. These are fascicled, sessile, cylindrical, variable in number and length, brown to black skinned and white after peeling. The fleshy roots are the economically important part, which contain saponins and are used for the preparation of many Ayurvedic tonics prescribed against general debility. The roots fetch an attractive market price at present (Rs. 900-1200/kg of dry roots). In nature, the plant regenerates soon after or immediately before the rainy season (May-June) from the previous year's dormant root present in the soil.
The many therapeutic applications of Safed Musli include as a restorative and a health-giving tonic; a curative for pre-natal and post-natal illness; and a remedy for diabetes, arthritis etc. Safed Musli supports physiological balance or homeostasis. It improves access to energy stores, helps to improve stamina and resistance to stress and tiredness, helps in mobilization of the bodys' nutritional resources, helps to normalize various indices such as blood pressure. While safed musli goes into over 200 ayurvedic preparations, it is known in countries like Saudi Arabia as an effective Indian Herbal Viagra.
The origin of Safed Musli can be traced back in the oldest mountain ranges on the continent, the Aravalis from where it spread to the near-by areas of the sub-continent, presently grown in the states of Gujrat, Rajasthan, Madhya Pradesh and the Central Deccan Plateau [38] and is thus endemic to India. The genus includes about 300 species, which are distributed throughout the tropical and subtropical parts of the world. Tropical and subtropical Africa is the probable Centre of Origin of the genus, where about 85% of the species are found. It is now widely cultivated in different parts of India on commercial basis. In India, about 13 species are reported [42] , of which seven species (C. tuberosum, C. arundinaceum, C. breviscapum, C. attenuatum, C. laxum, C. borivilianum and C. malabaricum) are commonly observed. Nowadays, there is a vast demand of C. borivilianum all over the world (specially gulf countries and cold countries). There are around 256 varieties of Chlorophytum in the world, which are known yet. The dried roots of C. borivilianum are the products of commerce. Dried powdered roots or its extracts are widely used in several herbal tonics [78] . The plant yields a flavonone glycoside, which is a powerful uterine stimulant. Dried roots of Chlorophytum contain 42% carbohydrate, 80-89% protein, 3-4% fiber and 2-17% saponin [104] . Research studies on Chlorophytum conducted in India and elsewhere indicate that saponins [38] are responsible for medicinal properties. A saponin (Fig. 3) is a category of phytonutrients (plant nutrients) found abundantly in many beans, and other plants such as ginseng, alfalfa, yucca, aloe, quinoa seed and also in Safed musli. Saponins in safed musli are known to ensure the defense of the plant against microbial or fungal attack. Several drugs owe their antiinflammatory and antiedemic properties to saponins. Fig. (3) . Saponin.
Similarly, many saponin containing drugs are traditionally used for their antitussive and expectorant properties. Low seed set, poor seed viability, high dormancy and low percentage of seed germination are some of the problems in propagation of some medicinal plants. Seeds set are extremely poor in safed musli. Recently, Fusarium solani was identified for the first time as causing a tuber-rot in safed musli [77] . To encourage its adoption as a crop plant, propagation and cultural methods have been investigated [44] . To overcome this problem, recently one of the rapidly expanding areas of pharmacognosy has involved the application of tissue culture of plant cells, tissues and organs in the study of medicinal plants [103] . Therefore attempts were made to propagate the material by in vitro methods. This method holds tremendous potential for the production of high-quality plant-based medicine.
Extensive work has been done on several ornamental species of family Liliaceae [46, 89, 102 ] but very few medicinal plants of this family have been cultured in vitro [39] . Biotechnological research on Chlorophytum borivilianum has been supported previously by central funding agencies. In nature it is a slow growing plant. Perusal of literature shows only a few reports on in vitro studies in C. borivilianum [20, 74, 75, 99] . Initially different explants like leaf base segments, stem disc with shoot meristem, sliced root tuber and young shoot buds were used as explants [37] .
In our laboratory, regeneration of C. borivilianum from both young shoot buds as well as inflorescence axis bearing an axillary bud gave good result [22] . Regeneration was successful both from the inflorescence axis (Fig. 4A) and young shoot buds (Fig. 4B) on MS basal medium supplemented with (1-5 mg l -1 ) BAP .In some cases, callusing and multiple shoot proliferation was also observed. These cultures later gave rise to 24 -35 shoots per culture from segments of inflorescence axis (Fig. 4C ) and 10-13 shoots per culture from young shoots buds (Fig. 4D) on MS medium containing 4mgl -1 BAP. The healthy shoots were transferred to 1/2 MS medium containing auxins for rooting (Fig. 4E) at various concentrations (0.5-2.5mgl -1 ) of IBA [23] . Rooted plantlets on agar solidified media were removed and subjected to different modes of hardening and acclimatization (Fig. 4F) .
Somatic embryogenesis in callus culture of Chlorophytum borivilianum was first observed in immature zygotic explants and intact ovules by Purohit et al. [76] . Callus induction was observed in embryos on the 10 th day after their inoculation on the MS medium containing 4.52µm-22.6µm of 2,4-D.However the best response was observed in the presence of 4.52µm of 2,4-D. Subculture to MS medium containing low concentration 2,4-D (1.13µm) and 567.0µm of ascorbic acid initiated faster growth of embryogenic cultures. Mature somatic embryos when transferred to medium without growth regulators, they germinate only when kept in light. The inoculated embryos gave rise to shoots and ultimately roots along with a mixed population of precociously germinating embryos showing profuse rhizogenesis. Encapsulation of young shoots buds and plantlets regeneration have been reported by Dave et al. [21] . in Chlorophytum borivilianum. Four millimeter long shoot buds encapsulated in 3.0%sodium alginate matrix polymerized by 100mM solution of CaCl 2 .2H 2 O yielded best results. Recently, Fluorescence In Situ Hybridization (FISH) technique has been applied on somatic chromosomes and extended DNA fibers in the medicinally important species of Chlorophytum to elucidate physical localization and measurement of the rDNA sites using two rRNA multigene families homologous to 45S and 5S rDNA [47] .
Water Hyssop, Bacopa monniera
Bacopa monniera, also referred to as Bacopa monnieri, Herpestis monniera, water hyssop, and "Brahmi", has been used in the Ayurvedic system of medicine for centuries. Bacopa monniera, a member of the Scrophulariaceae family, is a small, creeping herb with numerous branches, small oblong leaves, and light purple flowers. In India and the tropics it grows naturally in wet soil, shallow water, and marshes. The herb can be found at elevations from sea level to altitudes of 4,400 feet, and is easily cultivated if adequate water is available. Flowers and fruit appear in summer and the entire plant is used medicinally.
Bacopa monniera is traditionally prescribed in Ayurveda, a holistic system of medicine originating from India. Practitioners of Ayurveda classify Bacopa as a natural sedative and mood stabilizer, which is most often used to mildly relax the Central Nervous System (CNS) as well as, like focus and memory. Traditionally, it was used to support healthy cognitive functions, brain tonic to enhance memory development, learning, and concentration, and to provide relief to patients with anxiety or epileptic disorders. The plant has also been used in India and Pakistan as a cardiac tonic, digestive aid, and to improve respiratory function in cases of bronchoconstriction [15] . Brahmi may be useful for people who want to improve mental function and concentration particularly under pressure or in stressful conditions Research on anxiety, epilepsy, bronchitis and asthma, irritable bowel syndrome, and gastric ulcers also supports the Ayurvedic uses of Bacopa. Bacopa's antioxidant properties may offer protection from free radical damage in cardiovascular disease and certain types of cancer. All available medical literature [93, 94] confirms that there has been no toxicity report associated with the use of Bacopa as a dietary supplement in children or adults [18] .
Brahmi is especially suitable for students as it enhances the minds ability to learn and to focus [95] . In India the plant is used for all sorts of skin problems-eczema, psoriasis, abscess, ulceration, it is said to stimulate the growth of skin, hair and nails [51] . In vitro studies on anticancer studies of Bacopa monniera [28] have also been performed. Other studies have confirmed that Brahmi has a calming effect for stress and has become the herb of choice for attention deficit disorder A.D.D. in hyperactive children. The results of recent laboratory studies suggest that, in addition to its moodstabilizing effects, Bacopa also exhibit adaptogenic activity, which is thought to naturally increase the bodys' resistance to emotional stress and mental exhaustion [101] . Researchers have categorized multiple phytochemical compounds derived from Bacopa monniera extract, including Bacosides (Fig. 5) , Alkaloids and Glycosides. The active constituents in Brahmi are the all important steroidal saponins [79, 80, 81, 83, 91] .
The ontogenic and seasonal variation in accumulation of bacoside A in Bacopa monniera has been categorized [29] . A new 13,14-seco-steroid Bacosterol and bacosine, a new triterpene from Bacopa monniera [2] have also been isolated. A simple sensitive HPTLC method have been developed for the analysis of bacoside A in the plant Bacopa monnieri and in its commercial monoherbal capsule formulation. The proposed HPTLC method provides a faster and cost effective qualitative control for routine analysis of bacoside in formulations containing Bacopa monnieri saponins.
An effective protocol for mass propagation of Bacopa monnieri (L.) Pennell, an important medicinal plant [90] was developed using shoot tips and nodal segments as explants. Shoot regeneration and somatic embryogenesis from different explants of Brahmi.The explants were cultured on Murashige and Skoog's medium supplemented with various aux-ins, cytokinins either alone or with coconut milk and auxins plus cytokinins. Multiple shoots were obtained on MS medium supplemented with auxins or/and cytokinins with or without coconut milk. Maximum number of plants were obtained on medium containing KN/2-ip (0.1 mg/l) and KN (1 mg/1) in shoot tip and nodal cultures, respectively. The regenerated shoots developed roots on the same medium. In our lab, similar observation was noticed. The initiation of shoot proliferation (Fig. 6A,B,C) from nodal explants was observed on MS medium supplemented with BAP(1mgl -1 ) and KN (4mgl -1 ). When these were subcultured on MS medium supplemented with BAP (5mgl -1 ) multiple shoot. Bud proliferation was further enhanced .They were found to originate ,associated with or without roots. Shoot elongation (Fig. 6D) was observed on the same medium. These shoots when transferred to 1\2 MS medium supplemented with IBA (2mgl -1 ) resulted in rooting. Regenerated plantlets were transferred to soil after a very brief period of hardening. The regenerated plants are dark green in colour and more robust in their growth than the normal plants. These characters can be exploited further to determine somaclonal variations. Morphogenetic response [8] and isozymes of Bacopa monnieri cultivars grown under different conditions like salt stress [6] , bioaccumulation and biochemical effects of mercury [98] , copper stress [7] , influence of cadmium [4] and zinc [33] on growth and photosynthesis of Bacopa monniera cultivated in vitro has been identified. The application of high-performance liquid chromatography coupled to nuclear magnetic resonance spectrometry, mass spectrometry and bioassay has been performed for the determination of active saponins in Bacopa monniera [37] . A tracer technique have been used to evaluate bacoside A, in various Bacopa monniera accessions [30] . Dammarane-type triterpenoid saponins [31] and Bacopasaponin D, a pseudojujubogenin glycoside [32, 49, 52] .
Thornapple, Datura metel
Since time immemorial various Datura (Solanaceae) species have been referred sacred visionary plants by practically all cultures that have come into contact with it. Their distribution spans all warm and tropical regions of the world. Daturas usually grow as herbaceous annuals/perennials. The most striking feature, shared by all species are the beautiful trumpet-like flowers, ranging in color from white to pinkish purple, and in some varieties even to bright golden yellow and red. The flowers exude a beautiful, narcotic scent, especially at night. The seed capsules of the Datura species are typically the size of a walnut and are covered with thorns that may become quite sharp and spiky as the plant matures. The appearance of these seed-capsules has given rise to the English common name, 'Thorn apple'. It was used as a painkiller in certain initiation rituals and given as a narcotic to the ritual sacrifices. For this purpose the preferred method of administration was either by enema or as a rolled-up leaf suppository, which reduces some of the less pleasant side effects of the drug. Another type of Datura, called Atlinan by the Aztecs, enjoyed a particularly sacred status. It was regarded as the sister of Ololuiqui hallucinogenic plant. These plants were so sacred that only the priests were allowed to use them. With their help they held counsel with the Godsdivining the outcome of future events, discovering the whereabouts of lost or stolen objects and prognosticating the causes of diseases, especially if black magic was suspected. As a medicinal remedy they prepared an ointment for cracked soles and injured feet, made plasters for ulcers, pustules and infected wounds and skin sores, and used it for poultices to treat rheumatic aches and pains. Here too, the ancient use of Datura as a powerful aphrodisiac is clearly implied.
All species of Datura contain powerful alkaloids, which in sufficient quantities have the power to kill. The main alkaloids represented are Scopolamine, Hyoscyamine and Atropine (Fig. 7) . Self-experimentation is not recommended and must be strictly avoided by anyone who suffers any kind of heart condition.
The effects are stimulating on the central nervous system and simultaneously depressing on the peripheral nerves. Symptoms include an increased heart rate, drying up of the mucus membranes, a dry throat and sometimes cramps. At first the effects are arousing, sometimes manifesting as uncontrolled talking or laughing, forgetfulness and indulging in senseless repetitive activities. Vivid hallucinations and delirious illusions may also occur. Occasionally the effects can produce extreme violence and destructive urges. The period of agitation is usually followed by a deep prolonged sleep accompanied with vivid dreams and hallucinations, often of a sexual nature. Upon awakening one might experience a distinct hangover and a total lack of memory as to what actually happened during the state of altered consciousness.
All parts of the plant are anodyne, antispasmodic, hallucinogenic, hypnotic and narcotic. It has been used in the past as a painkiller and also in the treatment of insanity, fevers diarrhoea and skin diseases. The plant contains several alkaloids, the most active of which is scopolamine. This is a potent cholinergic-blocking hallucinogen, which has been used to calm schizoid patients. The leaves contain 0.52% scopolamine, the calices 1.08%, the stems 0.3%, the roots 0.39%, the fruits 0.77%, the capsules 0.33%, the seeds 0.44% and the whole plant 0.52 -0.62%. Any use of this plant should be with extreme caution and under the supervision of a qualified practitioner since the toxic dose is very close to the medicinal dose.
Tissue cell culture study of Datura metel [24] has been performed extensively. In vitro plant regeneration was achieved in Datura metel from nodal explants collected from both in vitro germinated seedlings and field grown plants (in vivo). The explants were cultured on MS medium with BAP (0.5-3.0 mgl -1 ) and NAA (0.5 mgl -1 ). The nodal explants isolated from in vivo source exhibited a greater number of healthy multiple shoots than in vitro. BAP at 3 mgl -1 with NAA at 0.5 mgl -1 was found to be optimal for regeneration of shootlets [63] . Arockiasamy, D. I., B. Muthukumar, et al. [9] raised from microspore-derived embryos [11] have been initiated. They have also studied the effects of using activated charcoal on microspore embryogenesis in Datura metel [12] .
High frequency plant regeneration from anther derived cell suspension culture via somatic embryogenesis was observed in Datura metel. Somatic embryos were found to be initiated from anther at the uninucleate stage in liquid MS medium supplemented with 2,4-D (0.2-0.4mgl -1 ). When subcultured after 3 days on semisolid liquid MS medium supplemented with 2,4-D (0.2-0.4mgl -1 ). These embryos became green and shoot buds (Fig. 8A ) stated initiating. Multiple shoot proliferation (Fig. 8B) was observed on subculturing on MS medium supplemented with BAP (2-5mgl -1 ) alone and in combination of NAA (0.2-0.5mgl -1 ) and Kinetin (2-4mgl -1 ). Shoot elongation was observed on MS medium supplemented with NAA (0.5mgl -1 ) and KN(2mgl -1 ). These shoots when transferred to MS medium supplemented with IBA (1-2mgl -1 ) resulted in rooting. For alkaloid extraction, in vitro plant multiplication is an ideal approach to produce leaf material in large quantity.
The characterization of the chemical constituents of Datura metel Linn.genotypes and alkaloid contents of Datura metel varieties [5] revealed the variation of scopolamine and atropine in different parts of the plant during development [1] and new withanolides, daturametelins C, D, E, F and GAc from Datura metel L. [92] . The structures of atropine, scopolamine [64] , withametelin and isowithametelin, withanolides [96] from Datura has been characterized. Pharmacognostical studies, variation of alkaloid contents in the seeds [66] and toxic effects of alkaloid extracts of Strychnos nux-vomica, Datura metel and Argemone mexicana on the behaviour of chromatophores and mucous glands of Indian minor carp [96] have been done. In vitro production of tropane alkaloids was also observed in Datura metel [17] . Hairy root lines of Datura metel were established following infection of aseptic stem segments with Agrobacterium rhizogenes strain A4 and cultured in hormone-free B5 solid medium. The growth and production of hyoscyamine and scopolamine (mg/g dry wt.) of these root cultures was encouraged by using B5 liquid medium with half-strength salts. Application of short GC column [50] in the analysis of some tropane alkaloids in plants have also been tried.
CONCLUSION
Micropropagation holds tremendous potential as a tool for the production of high quality plant-based medicines. Medicinal compounds from plants represent one of the largest and most diverse groups of plant secondary metabolites. The advent of advanced bioinformatics tools and modern genetic technology allowed manipulation of biosynthetic pathways with the potential of generating novel chemical entities. First, public databases of secondary metabolite related enzymes were interrogated to identify relevant plant genes from the plant and other species for the production of high-quality plant-based medicine. Protocols have been developed for clonal multiplication of hundreds of plant species, which include trees, medicinal and aromatic plants and endangered species from several laboratories across the country. Tissue culture protocols have been developed for several plants but there are many other species, which are over exploited in pharmaceutical industries and need conservation. It is now quite apparent that India has made big strides in the realm of biotechnology. The galloping rate, at which this advancement is continuing, holds out great promise for a better future.
In vitro propagation of medicinal plants with enriched bioactive principles and cell culture methodologies for selective metabolite production is found to be highly useful for commercial production of medicinally important compounds. The increased use of plant cell culture systems in recent years is perhaps due to an improved understanding of the secondary metabolite pathway in economically important plants. Advances in plant cell cultures could provide new means for the cost-effective, commercial production of even rare or exotic plants, their cells, and the chemicals that they will produce. Knowledge of the biosynthetic pathways of desired compounds in plants as well as of cultures is often still rudimentary, and strategies are consequently needed to develop information based on a cellular and molecular level. Because of the complex and incompletely understood nature of plant cells in in vitro cultures, case-by-case studies have been used to explain the problems occurring in the production of secondary metabolites from cultured plant cells. A key to the evaluation of strategies to improve productivity is the realization that all the problems must be seen in a holistic context. At any rate, substantial progress in improving secondary metabolite production from plant cell cultures has been made within last few years. These new technologies will serve to extend and enhance the continued usefulness of higher plants as renewable sources of chemicals, especially medicinal compounds.
Advances in tissue culture, combined with improvement in genetic engineering, specifically transformation technology, has opened new avenues for high volume production of pharmaceuticals, neutraceuticals, and other beneficial substances. Recent advances in the molecular biology, enzymology, and fermentation technology of plant cell cultures suggest that these systems will become a viable source of important secondary metabolites. Genome manipulation is resulting in relatively large amounts of desired compounds produced by plants infected with an engineered virus, whereas transgenic plants can maintain constant levels of production of proteins without additional intervention. Large-scale plant tissue culture is found to be an attractive alternative approach to traditional methods of plantation as it offers a controlled supply of biochemicals independent of plant availability. We hope that continuation and intensification efforts in this field will lead to controllable and successful biotechnological production of specific, valuable, and as yet unknown plant chemicals.
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